CRB3 and breast cancer: As a hyperactive downstream effector protein of the Hippo pathway, TAZ may promote tumorigenic potential by enhancing stem cell-like properties in breast cancer.21 CRB3 downregulation has been shown to be associated with TAZ localization in the nucleus.7 We showed that the expression of TAZ and other downstream factors were increased in CRB3-downregulated cells.